January 22, 2025 |Alumnus Aftab Ahmed MPP'23 wrote about growing as social media applications such as Facebook, Messenger, Instagram, Threads and WhatsAppcommandover three billion active monthly users worldwide. In the Policy Magazine, he wrote "Meta faces no competition capable of challenging its influence.
December 21, 2024 |Norman Hillmer (Slater Visiting Scholar) and Vincent Rigby co-edited with Phil Legasse from NPSIA, book named.The bookincludes articles by Jennifer Welsh DzChoices for Canada in a New Geopolitical
January 13, 2025 |Alumnus Anil Wasif MPP'21 wrote an as Canada braces for U.S. tariff threats of 25% after the newly elected Trump administration. The strategies disparity between the federal and provincial governments poses a greater problem.
It is with deep sadness that we remember Emil Skamene, a pioneer in genetic research at 㽶Ƶ.
His groundbreaking work on host genetic susceptibility to infections has shaped the field for over three decades.
Skamene’s legacy continues to inspire scientists, including D2R’s Chief Scientific Officer, Philippe Gros, who, alongside ProfessorErwin Schurr, honors him in a heartfelt eulogy published in Nature Genetics.
Academic and industry scientists collaborate on a new method to characterize research antibodies
First Hybrid Workshop on Precision Health and Medicine
Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.
This event is organized in partnership between University of Bern and 㽶Ƶ. This partnership between the universities aims to synergistically harness the power of new technologies in omics, digital sciences, and translational medicine to advance patient care.
Event details:
YCharOS antibody characterization platform addresses the “reproducibility crisis” in research
An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.
YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.
Dear Colleagues,
Please see the next Medical Genetics Grand Rounds scheduled talk below:
We're happy to announce that the 2024 Amazing Brain Science Talks video recordings are officially live on our YouTube channel. Whether you're tuning in for the first time or revisiting your favourite moments, don't miss out on these compelling talks!
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease
REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.
Philippe Gros appointed Chief Scientific Officer of D2R
Philippe Gros has been appointed Chief Scientific Officer (CSO) of McGill’s DNA to 㽶Ƶ (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at McGill. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.
D2R welcomes 㽶Ƶ and genomic researchers to Université de Sherbrooke
Montreal – October 31, 2024 – 㽶Ƶ’s DNA to 㽶Ƶ (D2R) research initiative is proud to announce the appointment of three new researchers at Université de Sherbrooke, marking the inaugural recipients of the D2R’s New Faculty Start-Up funding program. Université de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and 㽶Ƶ research.
October 22, 2024 |Alumnus Anil Wasif MPP'21 wrote an about the IMF and the World Bank initiating to promote global economic stability. It has been 80 years since the establishment of these institutions and new challenges have sprung.
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.